Try our beta test site

Psychiatric Problems in Chronic Skin Diseases

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00167752
First received: September 11, 2005
Last updated: October 24, 2016
Last verified: October 2016
  Purpose
The purpose of this study is to investigate the prevalence of depression, anxiety, and sleep problems in patients with chronic skin diseases in dermatology clinics at the University of Wisconsin Hospital and Clinics.

Condition
Psoriasis
Acne
Vitiligo
Atopic Dermatitis
Pruritic Dermatitis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quality of Life, Emotional and Sleep Problems in Chronic Skin Diseases

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Study Start Date: December 2002
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects suffering from a chronic skin condition that has lasted over six months

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00167752

Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Ladan Mostaghimi, MD University of Wisconsin, Madison
  More Information

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00167752     History of Changes
Other Study ID Numbers: 2002-0420 
Study First Received: September 11, 2005
Last Updated: October 24, 2016

Additional relevant MeSH terms:
Psoriasis
Dermatitis
Dermatitis, Atopic
Eczema
Vitiligo
Skin Diseases
Pruritus
Skin Diseases, Papulosquamous
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Hypopigmentation
Pigmentation Disorders
Skin Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on February 24, 2017